These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2372525)

  • 1. The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Br J Obstet Gynaecol; 1990 May; 97(5):406-11. PubMed ID: 2372525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester.
    Hill NC; Selinger M; Ferguson J; López Bernal A; Mackenzie IZ
    Br J Obstet Gynaecol; 1990 Jun; 97(6):487-92. PubMed ID: 2198918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
    Gupta JK; Johnson N
    Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
    Wang JD; Shi WL; Zhang GQ; Bai XM
    Contraception; 1994 Mar; 49(3):245-53. PubMed ID: 8200218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy.
    Thong KJ; Brooks AN; Baird DT
    Br J Obstet Gynaecol; 1993 Sep; 100(9):880-2. PubMed ID: 8218022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of RU 38,486 on progesterone and oestrogen receptor concentrations in the decidua and placenta in early pregnancy.
    Hill NC; Rivera J; Lopez Bernal A; MacKenzie IZ
    Hum Reprod; 1990 May; 5(4):464-7. PubMed ID: 2362009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy.
    Chard T; Olajide F; Kitau M
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1030-2. PubMed ID: 1701323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
    Lelaidier C; Baton-Saint-Mleux C; Fernandez H; Bourget P; Frydman R
    Hum Reprod; 1993 Mar; 8(3):492-5. PubMed ID: 8473474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.